The University of Chicago Header Logo

Application of genetically engineered tumor-specific Th1 cells to adoptive tumor immunotherapy

Application of genetically engineered tumor-specific Th1 cells to adoptive tumor immunotherapy. Annals of Cancer Research and Therapy. 2004; 12:71-86.